Healthcare Economist January 17, 2025
Jason Shafrin

From the CMS document “Medicare Drug Price Negotiation Program: Selected Drugs for Initial Price
Applicability Year 2027
“:

On January 17, 2025, CMS announced the selection of the below list of 15 drugs covered under Medicare Part D for the second cycle of negotiations (initial price applicability year 2027), based on total gross covered prescription drug costs under Medicare Part D and other criteria as required by the law.

With the Trump inauguration to take place on Monday, will the Medicare Drug Price Negotiation process change...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
The next wave: 2025 trends set to transform value-based care
Value-based payment models: Doctors describe the disconnect between theory and practice
How hospitals can prepare for CMS' new TEAM model
CMS suspends Hospice Special Focus Program
Prioritize Prior Authorization Reforms In Medicare Advantage

Share This Article